Global Hepatitis C Drugs Market Research Report 2023

Report ID: 1983433 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hepatitis C Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Anti-Viral
        1.2.3 Immuno-modulators
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Hepatitis C Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hepatitis C Drugs Market Perspective (2017-2028)
    2.2 Hepatitis C Drugs Growth Trends by Region
        2.2.1 Hepatitis C Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hepatitis C Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Hepatitis C Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Hepatitis C Drugs Market Dynamics
        2.3.1 Hepatitis C Drugs Industry Trends
        2.3.2 Hepatitis C Drugs Market Drivers
        2.3.3 Hepatitis C Drugs Market Challenges
        2.3.4 Hepatitis C Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hepatitis C Drugs Players by Revenue
        3.1.1 Global Top Hepatitis C Drugs Players by Revenue (2017-2022)
        3.1.2 Global Hepatitis C Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Hepatitis C Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hepatitis C Drugs Revenue
    3.4 Global Hepatitis C Drugs Market Concentration Ratio
        3.4.1 Global Hepatitis C Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Drugs Revenue in 2021
    3.5 Hepatitis C Drugs Key Players Head office and Area Served
    3.6 Key Players Hepatitis C Drugs Product Solution and Service
    3.7 Date of Enter into Hepatitis C Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis C Drugs Breakdown Data by Type
    4.1 Global Hepatitis C Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Hepatitis C Drugs Forecasted Market Size by Type (2023-2028)
5 Hepatitis C Drugs Breakdown Data by Application
    5.1 Global Hepatitis C Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Hepatitis C Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hepatitis C Drugs Market Size (2017-2028)
    6.2 North America Hepatitis C Drugs Market Size by Country (2017-2022)
    6.3 North America Hepatitis C Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Hepatitis C Drugs Market Size (2017-2028)
    7.2 Europe Hepatitis C Drugs Market Size by Country (2017-2022)
    7.3 Europe Hepatitis C Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hepatitis C Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Hepatitis C Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Hepatitis C Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Hepatitis C Drugs Market Size (2017-2028)
    9.2 Latin America Hepatitis C Drugs Market Size by Country (2017-2022)
    9.3 Latin America Hepatitis C Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hepatitis C Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Hepatitis C Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Hepatitis C Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Gilead sciences
        11.1.1 Gilead sciences Company Detail
        11.1.2 Gilead sciences Business Overview
        11.1.3 Gilead sciences Hepatitis C Drugs Introduction
        11.1.4 Gilead sciences Revenue in Hepatitis C Drugs Business (2017-2022)
        11.1.5 Gilead sciences Recent Development
    11.2 Abbvi
        11.2.1 Abbvi Company Detail
        11.2.2 Abbvi Business Overview
        11.2.3 Abbvi Hepatitis C Drugs Introduction
        11.2.4 Abbvi Revenue in Hepatitis C Drugs Business (2017-2022)
        11.2.5 Abbvi Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Detail
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Hepatitis C Drugs Introduction
        11.3.4 Johnson & Johnson Revenue in Hepatitis C Drugs Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Hepatitis C Drugs Introduction
        11.4.4 Merck Revenue in Hepatitis C Drugs Business (2017-2022)
        11.4.5 Merck Recent Development
    11.5 Glaxosmithkline
        11.5.1 Glaxosmithkline Company Detail
        11.5.2 Glaxosmithkline Business Overview
        11.5.3 Glaxosmithkline Hepatitis C Drugs Introduction
        11.5.4 Glaxosmithkline Revenue in Hepatitis C Drugs Business (2017-2022)
        11.5.5 Glaxosmithkline Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Detail
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Hepatitis C Drugs Introduction
        11.6.4 Novartis Revenue in Hepatitis C Drugs Business (2017-2022)
        11.6.5 Novartis Recent Development
    11.7 Bristol-Myers Squibb
        11.7.1 Bristol-Myers Squibb Company Detail
        11.7.2 Bristol-Myers Squibb Business Overview
        11.7.3 Bristol-Myers Squibb Hepatitis C Drugs Introduction
        11.7.4 Bristol-Myers Squibb Revenue in Hepatitis C Drugs Business (2017-2022)
        11.7.5 Bristol-Myers Squibb Recent Development
    11.8 Roche
        11.8.1 Roche Company Detail
        11.8.2 Roche Business Overview
        11.8.3 Roche Hepatitis C Drugs Introduction
        11.8.4 Roche Revenue in Hepatitis C Drugs Business (2017-2022)
        11.8.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Hepatitis C Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Anti-Viral
    Table 3. Key Players of Immuno-modulators
    Table 4. Key Players of Others
    Table 5. Global Hepatitis C Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Hepatitis C Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Hepatitis C Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Hepatitis C Drugs Market Share by Region (2017-2022)
    Table 9. Global Hepatitis C Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Hepatitis C Drugs Market Share by Region (2023-2028)
    Table 11. Hepatitis C Drugs Market Trends
    Table 12. Hepatitis C Drugs Market Drivers
    Table 13. Hepatitis C Drugs Market Challenges
    Table 14. Hepatitis C Drugs Market Restraints
    Table 15. Global Hepatitis C Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Hepatitis C Drugs Market Share by Players (2017-2022)
    Table 17. Global Top Hepatitis C Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Drugs as of 2021)
    Table 18. Ranking of Global Top Hepatitis C Drugs Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Hepatitis C Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Hepatitis C Drugs Product Solution and Service
    Table 22. Date of Enter into Hepatitis C Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Hepatitis C Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Hepatitis C Drugs Revenue Market Share by Type (2017-2022)
    Table 26. Global Hepatitis C Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Hepatitis C Drugs Revenue Market Share by Type (2023-2028)
    Table 28. Global Hepatitis C Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Hepatitis C Drugs Revenue Market Share by Application (2017-2022)
    Table 30. Global Hepatitis C Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Hepatitis C Drugs Revenue Market Share by Application (2023-2028)
    Table 32. North America Hepatitis C Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Hepatitis C Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Hepatitis C Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Hepatitis C Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Hepatitis C Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Hepatitis C Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Hepatitis C Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Hepatitis C Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Hepatitis C Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Hepatitis C Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Gilead sciences Company Detail
    Table 43. Gilead sciences Business Overview
    Table 44. Gilead sciences Hepatitis C Drugs Product
    Table 45. Gilead sciences Revenue in Hepatitis C Drugs Business (2017-2022) & (US$ Million)
    Table 46. Gilead sciences Recent Development
    Table 47. Abbvi Company Detail
    Table 48. Abbvi Business Overview
    Table 49. Abbvi Hepatitis C Drugs Product
    Table 50. Abbvi Revenue in Hepatitis C Drugs Business (2017-2022) & (US$ Million)
    Table 51. Abbvi Recent Development
    Table 52. Johnson & Johnson Company Detail
    Table 53. Johnson & Johnson Business Overview
    Table 54. Johnson & Johnson Hepatitis C Drugs Product
    Table 55. Johnson & Johnson Revenue in Hepatitis C Drugs Business (2017-2022) & (US$ Million)
    Table 56. Johnson & Johnson Recent Development
    Table 57. Merck Company Detail
    Table 58. Merck Business Overview
    Table 59. Merck Hepatitis C Drugs Product
    Table 60. Merck Revenue in Hepatitis C Drugs Business (2017-2022) & (US$ Million)
    Table 61. Merck Recent Development
    Table 62. Glaxosmithkline Company Detail
    Table 63. Glaxosmithkline Business Overview
    Table 64. Glaxosmithkline Hepatitis C Drugs Product
    Table 65. Glaxosmithkline Revenue in Hepatitis C Drugs Business (2017-2022) & (US$ Million)
    Table 66. Glaxosmithkline Recent Development
    Table 67. Novartis Company Detail
    Table 68. Novartis Business Overview
    Table 69. Novartis Hepatitis C Drugs Product
    Table 70. Novartis Revenue in Hepatitis C Drugs Business (2017-2022) & (US$ Million)
    Table 71. Novartis Recent Development
    Table 72. Bristol-Myers Squibb Company Detail
    Table 73. Bristol-Myers Squibb Business Overview
    Table 74. Bristol-Myers Squibb Hepatitis C Drugs Product
    Table 75. Bristol-Myers Squibb Revenue in Hepatitis C Drugs Business (2017-2022) & (US$ Million)
    Table 76. Bristol-Myers Squibb Recent Development
    Table 77. Roche Company Detail
    Table 78. Roche Business Overview
    Table 79. Roche Hepatitis C Drugs Product
    Table 80. Roche Revenue in Hepatitis C Drugs Business (2017-2022) & (US$ Million)
    Table 81. Roche Recent Development
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hepatitis C Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Anti-Viral Features
    Figure 3. Immuno-modulators Features
    Figure 4. Others Features
    Figure 5. Global Hepatitis C Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Hepatitis C Drugs Report Years Considered
    Figure 9. Global Hepatitis C Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Hepatitis C Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Hepatitis C Drugs Market Share by Region: 2021 VS 2028
    Figure 12. Global Hepatitis C Drugs Market Share by Players in 2021
    Figure 13. Global Top Hepatitis C Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Drugs as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Hepatitis C Drugs Revenue in 2021
    Figure 15. North America Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Hepatitis C Drugs Market Share by Country (2017-2028)
    Figure 17. United States Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Hepatitis C Drugs Market Share by Country (2017-2028)
    Figure 21. Germany Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Hepatitis C Drugs Market Share by Region (2017-2028)
    Figure 29. China Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Hepatitis C Drugs Market Share by Country (2017-2028)
    Figure 37. Mexico Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Hepatitis C Drugs Market Share by Country (2017-2028)
    Figure 41. Turkey Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Hepatitis C Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Gilead sciences Revenue Growth Rate in Hepatitis C Drugs Business (2017-2022)
    Figure 44. Abbvi Revenue Growth Rate in Hepatitis C Drugs Business (2017-2022)
    Figure 45. Johnson & Johnson Revenue Growth Rate in Hepatitis C Drugs Business (2017-2022)
    Figure 46. Merck Revenue Growth Rate in Hepatitis C Drugs Business (2017-2022)
    Figure 47. Glaxosmithkline Revenue Growth Rate in Hepatitis C Drugs Business (2017-2022)
    Figure 48. Novartis Revenue Growth Rate in Hepatitis C Drugs Business (2017-2022)
    Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis C Drugs Business (2017-2022)
    Figure 50. Roche Revenue Growth Rate in Hepatitis C Drugs Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gilead sciences
Abbvi
Johnson & Johnson
Merck
Glaxosmithkline
Novartis
Bristol-Myers Squibb
Roche
Frequently Asked Questions
Hepatitis C Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hepatitis C Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hepatitis C Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Herbal Toothpaste

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More